LONDON (Dow Jones)--ReGen Therapeutics PLC (RGT.LN), a U.K. developer of healthcare products, said Thursday it has recently ordered a custom made filtration unit for use in the production of its nutraceutical product Colostrinin. MAIN FACTS: -Previously ReGen has hired this equipment, which is used for a key stage in its proprietary Colostrinin production process, performed by its contract manufacturer Sterling Technology Inc., in Brookings, South Dakota, U.S.A. -Some of the monies raised during the summer were to fund this addition to the company's assets. -Shares closed Wednesday at 1.88 pence. -By Tommy Stubbington, Dow Jones Newswires; 44-20-7842-9268; tommy.stubbington@dowjones.com (END) Dow Jones Newswires July 29, 2010 02:59 ET (06:59 GMT)